RECALL · 28 OCT 2026CLASS IIRecalling firm: Shenzhen Techdow Pharmaceutical · Shenzhen

Techdow heparin recall: 251,000 vials without sterility assurance

Shenzhen Techdow recalled one lot of heparin sodium injection 5,000 units/mL sold in the US by Hepalink USA. The reason given is lack of assurance of sterility.

Is your product on this list?

Products at risk. Who's in.

Recalledin the firm's recall notice
MOLECULE FORM SOLD IN THE US BY LINK TO SITE RISK WHO'S IN Action
Heparin sodium Injection 5,000 USP units/mL, 1 mL multi-dose vial Hepalink USA RECALLED RECALLED 37 API (33 US DMF) · 20 FDF See who's in

FDA often redacts product names in its letters. Rows marked "FDA label" come from openFDA drug labels that name this site. "Who's in" counts manufacturers of the same molecule in the API-FDF database; names and contacts are inside.

What FDA found
  1. One lot, CU03232A, expiring 31 January 2028.
  2. 251,000 vials of 1 mL, distributed nationwide by Hepalink USA.
  3. Reason given: lack of assurance of sterility. FDA classed it Class II.
  4. Recall started on 1 October 2026.
Timeline

How it got here

1 OCT 2026 Techdow starts the recall
28 OCT 2026 FDA posts it as Class II

Techdow's heparin lot is recalled. 20 heparin injection makers are in.

Open the list on API-FDF